Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Helius Medical Technologies stock

Own Helius Medical Technologies stock in just a few minutes.

Helius Medical Technologies, Inc is a medical devices business based in the US. Helius Medical Technologies shares (HSDT) are listed on the NASDAQ and all prices are listed in US Dollars. Helius Medical Technologies employs 19 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Helius Medical Technologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HSDT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Helius Medical Technologies share price

Use our graph to track the performance of HSDT stocks over time.

Helius Medical Technologies shares at a glance

Information last updated 2021-04-28.
52-week range$11.00 - $23.77
50-day moving average $16.31
200-day moving average $14.92
Wall St. target price$2.12
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.34

Buy Helius Medical Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Helius Medical Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Helius Medical Technologies financials

Revenue TTM $622,000
Gross profit TTM $650,000
Return on assets TTM -110.59%
Return on equity TTM -281.65%
Profit margin 0%
Book value $2.47
Market capitalisation $25.8 million

TTM: trailing 12 months

Shorting Helius Medical Technologies shares

There are currently 112,159 Helius Medical Technologies shares held short by investors – that's known as Helius Medical Technologies's "short interest". This figure is 23.5% down from 146,667 last month.

There are a few different ways that this level of interest in shorting Helius Medical Technologies shares can be evaluated.

Helius Medical Technologies's "short interest ratio" (SIR)

Helius Medical Technologies's "short interest ratio" (SIR) is the quantity of Helius Medical Technologies shares currently shorted divided by the average quantity of Helius Medical Technologies shares traded daily (recently around 21042.96435272). Helius Medical Technologies's SIR currently stands at 5.33. In other words for every 100,000 Helius Medical Technologies shares traded daily on the market, roughly 5330 shares are currently held short.

However Helius Medical Technologies's short interest can also be evaluated against the total number of Helius Medical Technologies shares, or, against the total number of tradable Helius Medical Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Helius Medical Technologies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Helius Medical Technologies shares in existence, roughly 20 shares are currently held short) or 0.019% of the tradable shares (for every 100,000 tradable Helius Medical Technologies shares, roughly 19 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Helius Medical Technologies.

Find out more about how you can short Helius Medical Technologies stock.

Helius Medical Technologies share dividends

We're not expecting Helius Medical Technologies to pay a dividend over the next 12 months.

Have Helius Medical Technologies's shares ever split?

Helius Medical Technologies's shares were split on a 1:35 basis on 3 January 2021. So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Helius Medical Technologies shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for Helius Medical Technologies shares which in turn could have impacted Helius Medical Technologies's share price.

Helius Medical Technologies share price volatility

Over the last 12 months, Helius Medical Technologies's shares have ranged in value from as little as $11 up to $23.765. A popular way to gauge a stock's volatility is its "beta".

HSDT.US volatility(beta: 0.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Helius Medical Technologies's is 0.7706. This would suggest that Helius Medical Technologies's shares are less volatile than average (for this exchange).

Helius Medical Technologies overview

Helius Medical Technologies, Inc. , a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site